ARTICLE

FindCenter AddIcon

Psychedelic Support: Bridging Psychedelic Psychotherapy and Epigenetics

By Joseph Tafur — 2019

“Epigenetic changes will be measured after MDMA-assisted psychotherapy in a first of its kind study,” explains Dr. Joe Tafur about a research collaboration with MAPS investigators, the Modern Spirit research team, and the University of Southern California, Department of Psychiatry. The study will investigate ways MDMA-assisted psychotherapy may lead to measurable biochemical (“epigenetic”) change.

Read on maps.org

FindCenter Post-Image

Psychedelics and Race: A Profile of Dr. Monnica T. Williams

The exuberant “renaissance” of studies researching psychedelic-assisted psychotherapy in the past twenty years has not sufficiently included the enrollment of racially diverse participants, a problem that psychedelic science and clinical research shares with mainstream psychiatry

Article
Patricia Kubala
2020
FindCenter AddIcon
FindCenter Post-Image

MDMA-Assisted Couples Therapy: How a Psychedelic Is Enhancing Intimacy and Healing PTSD

Research over the last decade has shown MDMA-assisted psychotherapy to be effective in treating PTSD from military combat, sexual assault and childhood abuse. Now researchers are trialing MDMA with couples and finding promising results.

Article
Anne Wagner
2019
FindCenter AddIcon
FindCenter Post-Image

Psychedelics Could Trigger a ‘Paradigm Shift’ in Mental Health Care

A new review of studies finds that LSD, psilocybin, and MDMA hold potential for treating mental illness.

Article
Carolyn Gregoire
2015
FindCenter AddIcon
FindCenter Post-Image

Psychedelic Drugs Can Help Treat PTSD Caused by Racism, Discrimination: Researchers

Williams is the co-lead author of a recent retrospective study that found those who tried doses of psilocybin (more commonly known as magic mushrooms), LSD, or MDMA (the pure substance found in Ecstasy or Molly) reported a decrease in trauma symptoms, depression and anxiety after 30 days.

Article
Avis Favaro, Elizabeth St. Philip, Solarina Ho
2021
FindCenter AddIcon
FindCenter Post-Image

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

Article
Maureen Meehan
2017
FindCenter AddIcon
FindCenter Post-Image

The Interview: MDMA-Therapy Expert Dr. Rick Doblin

The world’s leading advocate for the medicinal use of psychedelics on the ghost of Timothy Leary, why Ecstasy could cure PTSD, and the best place to trip in Boston.

Article
Catherine Elton
2019
FindCenter AddIcon
FindCenter Post-Image

Why Microdosing MDMA Could Be A Bad Idea

As the trend of microdosing illustrates, if people want to reap the benefits of a substance, they’ll find the most effective way to do it. Everyone from entrepreneurs to artists are microdosing psychedelics like LSD, psilocybin, and mescaline for spiritual, creative, and productive enhancement.

Article
Patrick Smith
2017
FindCenter AddIcon
FindCenter Post-Image

Experimental Treatments Changed the Course of the AIDS Epidemic; We Need the Same Approach to Mental Illness Today | Commentary

Demand from patients seeking help for their mental illnesses has led to underground use in a way that parallels black markets in the AIDS pandemic. This underground use has been most perilous for people of color, who face greater stigma and legal risks due to the War on Drugs.

Article
Monnica Williams, Morgan Campbell
2021
FindCenter AddIcon
FindCenter Post-Image

Meet the Psychologist Using Psychedelics to Treat Racial Trauma

People of color are dealing with racism all the time, in large and small ways, and even dealing with racism in healthcare, even dealing with racism in therapy.

Article
Robin Donovan
2021
FindCenter AddIcon
FindCenter Post-Image

The Emergence of a New Market: Psychedelic Science Conferences

Many are talking about the “commodification of psychedelics” or the “new psychedelic businesses” or “corporations”; however, this boom is affecting all areas of our field.

Article
Bia Labate
FindCenter AddIcon

EXPLORE TOPIC

Epigenetics